Kura Oncology, Inc. (KURA)
2025-06-30 | 2025-03-31 | |||
|---|---|---|---|---|
| Total revenue | 15,288 | 14,108 | ||
| Research and development | 62,785 | 55,973 | ||
| General and administrative | 25,169 | 22,835 | ||
| Total operating expenses | 87,954 | 78,808 | ||
| Loss from operations | -72,666 | -64,700 | ||
| Interest expense | 391 | 382 | ||
| Interest and other income | 6,935 | 7,879 | ||
| Total other income, net | 6,544 | 7,497 | ||
| Loss before income taxes | -66,122 | -57,203 | ||
| Income tax expense | - | 226 | ||
| Net loss | -66,122 | -57,429 | ||
| Earnings per share, basic, total | -0.75 | -0.66 | ||
| Earnings per share, diluted, total | -0.75 | -0.66 | ||
| Weighted average number of shares outstanding, basic, total | 87,586,000 | 87,415,000 | ||
| Weighted average number of shares outstanding, diluted, total | 87,586,000 | 87,415,000 | ||